Emerging targets of biologic therapies for rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Emerging targets of biologic therapies for rheumatoid arthritis.

Emerging targets of biologic therapies for rheumatoid arthritis.

http://www.wikidata.org/entity/Q36835533

about

Herbal therapy for treating rheumatoid arthritis Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes.Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.Molecular mechanisms regulating NETosis in infection and disease.The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis.NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.Regulation of biomechanical signals by NF-kappaB transcription factors in chondrocytes.Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.Update on Targets of Biologic Therapies for Rheumatoid Arthritis.Nanotherapeutic approaches for the treatment of rheumatoid arthritis.Monoclonal antibody treatments for rheumatoid arthritis.Therapeutic targets for rheumatoid arthritis: Progress and promises.Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.Comparison of characteristics and therapeutic efficacy in rheumatoid arthritis patients treated by rheumatologists and those treated by orthopedic surgeons under a team medicine approach at the same institute.

P2860

Q24236611-11C952B6-80FA-43A5-AEE7-744C8DE04699 Q34346400-933A1F08-63C1-446F-8979-E06DFAB71665 Q35092982-FE7D8B1A-BEA0-46F8-A0E0-94910BBC2137 Q36937929-F24F420E-E7F8-4F32-B0A7-6BF03DFD7B83 Q36955377-36B91573-61C0-4799-A4F1-21D2B1FE5FA2 Q36961298-B171AB7F-D759-4B2C-B02B-62D15E6C5C1E Q37056181-2FFB0014-1FB3-4E39-9D11-F3FD5B88CE4D Q37164125-6CCB212C-50C4-456F-A760-1C9A10828BE2 Q37286980-6CF3BE43-36EE-451C-8983-8C85DD608E51 Q37326948-8A0BAE22-C820-4225-AC8E-066B22E958CF Q37694304-8307C0AC-F6ED-42E3-BC5C-6D2064CDD1A5 Q37916426-F5CEEAAC-9040-4F63-86B0-D616E08318D0 Q38116065-2F75B1A8-AF5D-472D-8809-8B0782031CDE Q38179461-7614502E-D416-4B8C-9506-365788567816 Q40063162-A1536E22-C465-45EA-961B-A6142A941141 Q42475068-8DF33452-908C-431B-8D0B-D622CC8FC544 Q43880563-4AB790E1-B08F-4FCE-83ED-9F34DFDDB1C3

P2860

Emerging targets of biologic therapies for rheumatoid arthritis.

http://www.wikidata.org/entity/Q36835533

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Emerging targets of biologic therapies for rheumatoid arthritis.

@en

type

label

Emerging targets of biologic therapies for rheumatoid arthritis.

@en

prefLabel

Emerging targets of biologic therapies for rheumatoid arthritis.

@en

P1433

Q36835533-D1515081-BD8F-440F-8692-80A3D19FBAFA

P1476

Q36835533-280BDD99-A582-44BF-8889-4B3C010D7065

P2093

Q36835533-0480D374-AEF6-4221-AB82-364E468DA065

Q36835533-C43C17A3-101F-48B3-9438-E80EE9BFA817

P2860

Q36835533-1D0ADCFF-1CA0-4823-87CF-CBEE2E2EF151

Q36835533-8AC854D6-3763-4CCA-8441-63348B3EEBC7

Q36835533-9A1DBCF5-F9EA-4903-8D7E-79EA51944A73

Q36835533-BD654E12-D415-4271-B8C0-3B6AB988615D

Q36835533-CA7628EC-8B90-4D57-85A1-1B87D1429651

Q36835533-D183E169-16ED-4636-801D-B35F7FE1A5CE

Q36835533-D1EFDAE2-7A2B-4CA7-8108-50CE49BA6A13

Q36835533-FEAD31D7-AAA1-475A-84B7-86578AF8EB79

P304

Q36835533-FC36D32A-65AA-45D6-A837-A35FDCB3536D

P31

Q36835533-9BD67BF7-AE0F-44FD-BD8E-6F7C0E37E3F8

P356

Q36835533-6D52DE45-F703-4EAB-8D5B-5E59FBC1074B

P433

Q36835533-A8F0C4F0-B888-44CE-979B-16256590932F

P478

Q36835533-7E1179DC-4F1F-4E5F-A9CC-2ACC219BC04E

P50

Q36835533-FB3CDD59-74D2-467B-8210-881B76E3F268

P577

Q36835533-3B95BFE1-7C45-40F8-8DBD-194F08389BE6

P698

Q36835533-BFA286EE-641D-4E18-8AD2-3F92172781B3

P356

P1433

Nature Clinical Practice Rheumatology

P1476

Emerging targets of biologic therapies for rheumatoid arthritis.

@en

P2093

Ingo H Tarner

http://www.w3.org/2001/XMLSchema#string

Steffen Gay

http://www.w3.org/2001/XMLSchema#string

P2860

The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis

Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis.

A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death.

Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.

IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate.

P304

336-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPRHEUM0506

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Ulf Müller-Ladner

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17538565

http://www.w3.org/2001/XMLSchema#string